Upgrade to SI Premium - Free Trial

Regulus Therapeutics (RGLS) PT Raised to $1.37 at BMO Capital, Sees Shares 'Range-Bound'

March 8, 2018 5:52 AM
BMO Capital raised its price target on Regulus Therapeutics (NASDAQ: RGLS) to $1.37 (from ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS View Analyst PT Change

Next Articles